Impact of hormone-therapy used in CRPC patients: evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice

Martine Dubois (1, 2, 3) , Tareq Al Sagheer (1) , Cynthia Campart (1) , Laurence Desrues (1, 2) , Marie Lange (4, 5, 3) , Pierrick Gandolfo (1, 2) , Florence Joly (5, 3) , Hélène Castel (1, 2, 3)

1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 DC2N - Différenciation et communication neuronale et neuroendocrine
3 Plateforme Cancer et Cognition
4 CRC - Centre de recherche clinique [CHU Caen]
5 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]

Domains: Life Sciences [q-bio]; Cancer; Cognitive science

Martine Dubois, Tareq Al Sagheer, Cynthia Campart, Laurence Desrues, Marie Lange, et al.. Impact of hormone-therapy used in CRPC patients: evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice. ASCO annual meeting, May 2019, Chicago, United States. ⟨hal-02335627⟩